.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077887

« Back to Dashboard
NDA 077887 describes CARVEDILOL, which is a drug marketed by Zydus Pharms Usa Inc, Mylan, Lupin, Sandoz, Aurobindo Pharma, Pliva Hrvatska Doo, Sun Pharm Inds Inc, Dr Reddys Labs Ltd, Glenmark Generics, Apotex Inc, Teva, Cipla Ltd, Taro, Beximco Usa, Wockhardt Ltd, Hikma, and Sun Pharm Inds Ltd, and is included in seventeen NDAs. It is available from fifty-one suppliers. Additional details are available on the CARVEDILOL profile page.

The generic ingredient in CARVEDILOL is carvedilol. There are thirty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the carvedilol profile page.

Summary for NDA: 077887

Tradename:
CARVEDILOL
Applicant:
Hikma
Ingredient:
carvedilol
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 077887

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARVEDILOL
carvedilol
TABLET;ORAL 077887 ANDA Hikma Pharmaceutical 59115-047 59115-047-01 100 TABLET, FILM COATED in 1 BOTTLE (59115-047-01)
CARVEDILOL
carvedilol
TABLET;ORAL 077887 ANDA Hikma Pharmaceutical 59115-048 59115-048-01 100 TABLET, FILM COATED in 1 BOTTLE (59115-048-01)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength3.125MG
Approval Date:Sep 7, 2007TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength6.25MG
Approval Date:Sep 7, 2007TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG
Approval Date:Sep 7, 2007TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc